Save your place

Sign in to WhoBought

Please try again later.

Arrowhead Pharmaceuticals, Inc. (ARWR) institutional ownership

Latest close $71.65 Jul 20, 2026
Market cap$2.2B 52-week range SectorHealthcare
Funds holding · Q1 2026
434
reported ARWR position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
260 buyers · 174 sellers

Arrowhead Pharmaceuticals, Inc. (ARWR) price and institutional activity

Dates

Q1 2026

$0 bought by 260 investors
Invesco Ltd.Fred Alger Management, LLC +258 more
$0 sold by 174 investors
BlackRockSlate Path Capital LP +172 more
Bought Sold Totals per quarter; hover a bar for the names.

Arrowhead Pharmaceuticals, Inc. (ARWR) institutional activity · 434

Investor Type Est. change Change Δ Own Date
BlackRock · Reduced
Change −3.2M Date Q1 2026
BlackRock Reduced· Q1 2026 −3.2M Q1 2026
Invesco Ltd. · Added
Change +2.7M Δ Own +498.9% Date Q1 2026
Invesco Ltd. Added· Q1 2026 +2.7M +498.9% Q1 2026
Slate Path Capital LP · Exited
Change −2.5M Δ Own −100.0% Date Q1 2026
Slate Path Capital LP Exited· Q1 2026 −2.5M −100.0% Q1 2026
Norges · Exited
Change −1.7M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −1.7M −100.0% Q1 2026
Fred Alger Management, LLC · Added
Change +1.5M Date Q1 2026
Fred Alger Management, LLC Added· Q1 2026 +1.5M Q1 2026
Arrowstreet Capital, Limited Partnership · Reduced
Change −1.5M Date Q1 2026
Arrowstreet Capital, Limited Partnership Reduced· Q1 2026 −1.5M Q1 2026
Vestal Point Capital, LP · Added
Change +1.4M Date Q1 2026
Vestal Point Capital, LP Added· Q1 2026 +1.4M Q1 2026
Hood River Capital Management LLC · New
Change +1.1M Date Q1 2026
Hood River Capital Management LLC New· Q1 2026 +1.1M Q1 2026
D. E. Shaw & Co., Inc. · Added
Change +1.0M Δ Own +710.5% Date Q1 2026
D. E. Shaw & Co., Inc. Added· Q1 2026 +1.0M +710.5% Q1 2026
Renaissance Technologies LLC New· Q1 2026 +1.0M Q1 2026
Geode · Added
Change +1.0M Date Q1 2026
Geode Added· Q1 2026 +1.0M Q1 2026
Vanguard · Reduced
Change −939K Date Q1 2026
Vanguard Reduced· Q1 2026 −939K Q1 2026
FMR LLC · Added
Change +746K Δ Own +11.4% Date Q1 2026
FMR LLC Added· Q1 2026 +746K +11.4% Q1 2026
American Century Companies Inc · Added
Change +644K Date Q1 2026
American Century Companies Inc Added· Q1 2026 +644K Q1 2026
Assenagon Asset Management S.A. · Reduced
Change −626K Date Q1 2026
Assenagon Asset Management S.A. Reduced· Q1 2026 −626K Q1 2026
Data through Q1 2026 · filed Jun 8, 2026
15 of 434

Famous investor activity in Arrowhead Pharmaceuticals, Inc. (ARWR)

Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Cohen Matthew Gregory · Director Grant (A) 12K
Owned 12K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Cohen Matthew Gregory Director Grant (A) 12K 12K Jun 15, 2026 Jun 17, 2026
Lu Hongbo · Director Sell −$228K
Price $76.88 Qty −3K Owned 52K Trade date May 12, 2026 Filed date May 14, 2026
Lu Hongbo Director Sell $76.88 −3K −$228K 52K May 12, 2026 May 14, 2026
Hamilton James C. · Officer Sell −$750K
Price $75.00 Qty −10K Owned 227K Trade date Apr 23, 2026 Filed date Apr 24, 2026
Hamilton James C. Officer Sell $75.00 −10K −$750K 227K Apr 23, 2026 Apr 24, 2026
Apel Daniel Joseph · CFO 3 operations −$934K
Price $70.11–$71.92 Qty −13K Owned 163K Trade date Apr 22, 2026 Filed date Apr 24, 2026
Apel Daniel Joseph CFO 3 operations $70.11–$71.92 −13K −$934K 163K Apr 22, 2026 Apr 24, 2026
Hamilton James C. · Officer Sell −$642K
Price $64.19 Qty −10K Owned 237K Trade date Mar 5, 2026 Filed date Mar 9, 2026
Hamilton James C. Officer Sell $64.19 −10K −$642K 237K Mar 5, 2026 Mar 9, 2026
Hamilton James C. · Officer Grant (A) 75K
Owned 247K Trade date Jan 6, 2026 Filed date Jan 8, 2026
Hamilton James C. Officer Grant (A) 75K 247K Jan 6, 2026 Jan 8, 2026
Apel Daniel Joseph · CFO Grant (A) 75K
Owned 176K Trade date Jan 6, 2026 Filed date Jan 8, 2026
Apel Daniel Joseph CFO Grant (A) 75K 176K Jan 6, 2026 Jan 8, 2026
O'Brien Patrick · Officer 5 operations -2K
Owned 473K Trade date Jan 6, 2026 Filed date Jan 8, 2026
O'Brien Patrick Officer 5 operations -2K 473K Jan 6, 2026 Jan 8, 2026
O'Brien Patrick · Officer Grant (A) 75K
Owned 547K Trade date Jan 6, 2026 Filed date Jan 8, 2026
O'Brien Patrick Officer Grant (A) 75K 547K Jan 6, 2026 Jan 8, 2026
O'Brien Patrick · Officer 12 operations −$3.1M
Price $61.12–$68.00 Qty −49K Owned 475K Trade date Jan 5, 2026 Filed date Jan 5, 2026
O'Brien Patrick Officer 12 operations $61.12–$68.00 −49K −$3.1M 475K Jan 5, 2026 Jan 5, 2026
Hamilton James C. · Officer 7 operations −$2.5M
Price $61.24–$68.00 Qty −40K Owned 174K Trade date Jan 5, 2026 Filed date Jan 5, 2026
Hamilton James C. Officer 7 operations $61.24–$68.00 −40K −$2.5M 174K Jan 5, 2026 Jan 5, 2026
Anzalone Christopher Richard · Director, Officer 2 operations −$872K
Price $65.88–$66.39 Qty −13K Owned 3.8M Trade date Jan 2, 2026 Filed date Jan 5, 2026
Anzalone Christopher Richard Director, Officer 2 operations $65.88–$66.39 −13K −$872K 3.8M Jan 2, 2026 Jan 5, 2026
O'Brien Patrick · Officer 5 operations -3K
Owned 526K Trade date Dec 31, 2025 Filed date Jan 5, 2026
O'Brien Patrick Officer 5 operations -3K 526K Dec 31, 2025 Jan 5, 2026
Anzalone Christopher Richard · Director, Officer 2 operations −$3.6M
Price $68.69–$69.33 Qty −52K Owned 3.8M Trade date Dec 29, 2025 Filed date Dec 30, 2025
Anzalone Christopher Richard Director, Officer 2 operations $68.69–$69.33 −52K −$3.6M 3.8M Dec 29, 2025 Dec 30, 2025
Anzalone Christopher Richard · Director, Officer 4 operations 0
Price $6.15 Owned 17K Trade date Dec 29, 2025 Filed date Dec 30, 2025
Anzalone Christopher Richard Director, Officer 4 operations $6.15 0 17K Dec 29, 2025 Dec 30, 2025
15 of 39
15 of 39 Sign in to continue to older insider transactions.

Arrowhead Pharmaceuticals, Inc. (ARWR) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 13.3M
% of shares outstanding 12.4% Filing date Jan 23, 2024
BlackRock Inc. 13.3M 12.4% Jan 23, 2024
Blackrock, Inc. 17.1M
% of shares outstanding 12.2% Filing date Apr 24, 2026
Blackrock, Inc. 17.1M 12.2% Apr 24, 2026
Vanguard Group Inc 12.4M
% of shares outstanding 10.0% Filing date Apr 10, 2024
Vanguard Group Inc 12.4M 10.0% Apr 10, 2024
Avoro Capital Advisors LLC 8.9M
% of shares outstanding 7.2% Filing date Nov 14, 2024
Avoro Capital Advisors LLC 8.9M 7.2% Nov 14, 2024
FMR LLC 7.3M
% of shares outstanding 5.2% Filing date May 6, 2026
FMR LLC 7.3M 5.2% May 6, 2026
Vanguard Portfolio Management LLC 7.3M
% of shares outstanding 5.2% Filing date Apr 28, 2026
Vanguard Portfolio Management LLC 7.3M 5.2% Apr 28, 2026
State Street Corp 6.4M
% of shares outstanding 5.1% Filing date Oct 16, 2024
State Street Corp 6.4M 5.1% Oct 16, 2024
Vanguard Capital Management LLC 7.1M
% of shares outstanding 5.0% Filing date Apr 29, 2026
Vanguard Capital Management LLC 7.1M 5.0% Apr 29, 2026
8 of 8

Arrowhead Pharmaceuticals, Inc. (ARWR) ownership FAQ

Who owns ARWR?

434 reporting institutions disclosed ARWR position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.